Combating Illicit Xylazine Act
The Combating Illicit Xylazine Act classifies xylazine as a controlled substance, aiming to curb its misuse in drugs and enhance public health and treatment efforts.
Sponsored Legislation
The Combating Illicit Xylazine Act classifies xylazine as a controlled substance, aiming to curb its misuse in drugs and enhance public health and treatment efforts.
HR 4525 ensures patients can access FDA-approved medications without barriers, enhancing treatment availability and requiring transparency from insurers and providers.
Ellie’s Law boosts research and awareness for critical health issues, benefiting patients, families, and healthcare providers through funding and public campaigns.
HR 2199 strengthens protections for dialysis patients, ensuring access to care, enhancing patient rights, and improving treatment quality in dialysis facilities.
We're glad to see you!
New to WeVote? Claim your Voter Profile now!
Are you an elected rep? Claim account
Join thousands of verified voters to weigh in.
Already have an account? Log in
Are you an elected rep? Claim account
No worries! Enter your email and we'll send you reset instructions.
Remember your password? Back to Login